SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
8.73
-1.86 (-17.56%)
At close: Jun 2, 2026, 4:00 PM EDT
8.64
-0.09 (-1.03%)
Pre-market: Jun 3, 2026, 5:36 AM EDT
SciSparc Employees
SciSparc had 3 employees as of December 31, 2025. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$285,333
Profits / Employee
-$4,059,667
Market Cap
5.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 1 | 50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| GeoVax Labs | 19 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
SPRC News
- 5 days ago - SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - GlobeNewsWire
- 13 days ago - Neurothera Labs Announces Adoption of Semi-Annual Reporting - TheNewswire
- 4 weeks ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 5 weeks ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 2 months ago - SciSparc discloses patent application for depression yherapy - TheFly
- 2 months ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire
- 2 months ago - SciSparc’s Neurothera Labs announces publication of international patent - TheFly
- 2 months ago - SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire